Skip to main content
  • 68 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aversa SML, Salvagno L, Chiarion-Sileni V et al. (1995) Treatment of HlV-asso-ciated Kaposi’s sarcoma (KS). Proc ASCO 14:291

    Google Scholar 

  2. Bakker PJ, Danner SA, Lange JM, Veenhof KH (1988) Etoposide for epidemic Kaposi’s sarcoma: a phase II study. Eur J Cancer Clin Oncol, 24:1047–1048

    Article  PubMed  CAS  Google Scholar 

  3. Bernstein L, Hamilton AS (1993) The epidemiology of AIDS-related malignancies. Current Op Oncol 5:822–830

    Article  CAS  Google Scholar 

  4. Bufill JA, Grace WR, Astrow AB (1992) Phase-II trial of prolonged low-dose oral VP-16 in AIDS related Kaposi’s sarcoma (KS). Proc ASCO 11:47

    Google Scholar 

  5. Cockerell C J (1991) Histopathological features of Kaposi’s sarcoma in HIV infected individuals. Cancer Surveys 10:73–89

    PubMed  CAS  Google Scholar 

  6. Evans LM, Itri LM, Campion M et al. (1991) Interferon-a2a in the treatment of acquired immunodeficiency syndrome-related Kaposi’s sarcoma. J Immunother 10:39–50

    Article  PubMed  CAS  Google Scholar 

  7. Fischl MA, Krown SE, O’Boyle KP et al. (1993) Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi’s sarcoma: J Acq Immune Def Syndromes 6:259–264

    CAS  Google Scholar 

  8. Foreman KE, Friborg J, Kong W-P et al. (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma. N Engl J Med 336:163–171

    Article  PubMed  CAS  Google Scholar 

  9. Gill P, Rarick M, Bernstein-Singer M et al. (1990) Treatment of advanced Kaposi’s sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 13: 315–319

    Article  PubMed  CAS  Google Scholar 

  10. Gill PS, Rarick MU, Mc Cutchan JA et al. (1991) Systemic treatment of AIDS-related Kaposi’s sarcoma: Results of a randomized trial. Am J Med 90:427–433

    PubMed  CAS  Google Scholar 

  11. Gill PS, Wernz J, Scadden DT et al. (1995) A randomized trial of liposomal dauno-rubicin (daunoxome) versus adriamycin, bleomycin and vincristine (ABV) in 232 patients with advanced AIDS-related Kaposi’s sarcoma. Proc. ASCO 14:291

    Google Scholar 

  12. Gill PS, Tulpule A, Reynolds T et al. (1996) Paclitaxel (Taxol) in the treatment of relapsed or refractory advanced AIDS-related Kaposi’s sarcoma. Proc ASCO 15: 306

    Google Scholar 

  13. Glaspy J, Miles S, McCarthy S et al. (1986) Treatment of advanced staged Kaposi’s sarcoma with vincristine and bleomycin. Proc ASCO 5:3

    Google Scholar 

  14. Groopman JE, Gottlieb MS, Goodman J et al. (1984) Recombinant alpha-2 interferon therapy for Kaposi’s sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 100:671–676

    Article  PubMed  CAS  Google Scholar 

  15. Guermonprez G, Katlama C, Caumes E et al. (1990) Bleomycin in the treatment of AIDS-related Kaposi’s sarcoma. Sixth Intern Conf AIDS 3:213

    Google Scholar 

  16. Hernandez DE, Perez JR (1996) Treatment of advanced epidemic Kaposi’s sarcoma (EKS) with bleomycin or a combination of doxorubicin, bleomycin, vincristine. Proc ASCO 15:308

    Google Scholar 

  17. Kaplan L, Abrams D, Volberding P (1986) Treatment of Kaposi’s sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer treat Rep 70:1121–1122

    PubMed  CAS  Google Scholar 

  18. Klein E, Schwartz RA, Laor Y et al. (1980) Treatment of Kaposi’s sarcoma with vinblastine. Cancer 45:427–431

    Article  PubMed  CAS  Google Scholar 

  19. Krigel RL, Slywotzky CM, Lonberg M et al. (1988) Treatment of epidemic Kaposi’s sarcoma with a combination of interferon-alpha 2b and etoposide. J Biol Resp Mod 7:359–364

    CAS  Google Scholar 

  20. Krown SE, Metroka C, Wernz JC (1989) Kaposi’s sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response and staging criteria. J Clin Oncol 7:1201–1207

    PubMed  CAS  Google Scholar 

  21. Krown SE (1990) Approaches to interferon combination therapy in the treatment of AIDS. Sem Oncol 17(1, Suppl 1): 11–15

    CAS  Google Scholar 

  22. Krown SE, Gold JWM, Niedzwiecki D et al. (1990) Interferon-a with Zidovudine: Safety, tolerance, and clinical and virologic effect in patients with Kaposi sarcoma associated with the aquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812–821

    Article  PubMed  CAS  Google Scholar 

  23. Lassoued K, Clauvel J-P, Katlama C et al. (1990) Treatment of the acquired immune deficiency syndrome-related Kaposi’s sarcoma with bleomycin as a single agent. Cancer 66:1869–1872

    Article  PubMed  CAS  Google Scholar 

  24. Laubenstein LJ, Krigel RL, Odajnyk CM et al. (1984) Treatment of epidemic Kaposi’s sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115–1120

    PubMed  CAS  Google Scholar 

  25. Mintzer DM, Real FX, Jovino L, Krown SE (1985) Treatment of Kaposi’s sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102:200–202

    Article  PubMed  CAS  Google Scholar 

  26. Mitrou PS (1996) Management of Kaposi’s sarcoma. Onkologie 19:49–52

    Article  Google Scholar 

  27. Mitsuyasu RT (1993) Clinical aspects of AIDS-related Kaposi’s sarcoma: Current Op Oncol 5:835–844

    Article  CAS  Google Scholar 

  28. Mitsuyasu RT, Gill P, Paredes J et al. (1995) Combination chemotherapy, adria-mycin, bleomycin, vincristine (ABV) with dideoxyinosine (ddl) or dideoxycytidine (ddc) in advanced AIDS-related Kaposi’s sarcoma (ACTG 163). Proc ASCO 14:289

    Google Scholar 

  29. Rabkin CS (1994) Epidemiology of AIDS-related malignancies. Current Op Oncol 6:492–496

    Article  CAS  Google Scholar 

  30. Rarick MU, Gill PS, Montgomery T et al. (1990) Treatment of epidemic Kaposi’s sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1:147–149

    PubMed  CAS  Google Scholar 

  31. Real FX, Oettgen HF, Krown SE (1986) Kaposi’s sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 4:544–551

    PubMed  CAS  Google Scholar 

  32. Remick SC, Reddy M, Hermann D et al. (1994) Continuous infusion bleomycin in AIDS-related Kaposi’s sarcoma. J Clin Oncol 12:1130–1136

    PubMed  CAS  Google Scholar 

  33. Saville MW, Lietzau J, Pluda JM et al. (1995) Treatment of HIV-associated Kaposi’s sarcoma with paclitaxel. Lancet 346:26–28

    Article  PubMed  CAS  Google Scholar 

  34. Volberding P, Conant MA, Strieker RB, Lewis BJ (1983) Chemotherapy in advanced Kaposi’s sarcoma. Amer J Med 74:625–656

    Article  Google Scholar 

  35. Volberding PA, Abrams DI, Conant M et al. (1985) Vinblastine therapy for Kaposi’s sarcoma in the acquired immune deficiency syndrome. Ann Intern Med 103: 335–338

    Article  PubMed  CAS  Google Scholar 

  36. Volm MD, von Roenn JM (1995) Treatment strategies for epidemic Kaposi’s sarcoma. Curr Op Oncol 7:429–436

    Article  CAS  Google Scholar 

  37. Wernz J, Laubenstein L, Hymes K et al. (1986) Chemotherapy and assessment of response in epidemic Kaposi’s sarcoma (EKS) with bleomycin (B)/Velban (V). Proc ASCO 5:4

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mitrou, P.S. (1998). Kaposi-Sarkom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10493-4_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10493-4_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63821-6

  • Online ISBN: 978-3-662-10493-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics